Clinical Trial Update: Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update for Anti-CD70-CAR-T Cell injection targeting CD70+ renal cell carcinoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Anti-CD70-CAR-T Cell Injection

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Renal Cell Carcinoma | EARLY_Phase 1 | Status: RECRUITING